Recently, Blé de Fonty, a pioneer in the concept and research of zone-specific anti-aging in the skincare field, successfully published its groundbreaking findings on Osteopeptide anti-aging mechanisms in the internationally renowned Journal of Cosmetic Dermatology. As one of the most influential academic journals in cosmetic science, the publication is known for its rigorous review standards and extensive industry impact. Its endorsement provides strong academic validation for Blé de Fonty’s scientific achievements, further consolidating the brand’s leadership in skincare innovation.

For years, the Blé de Fonty Laboratory has adhered to a spirit of scientific exploration, leading its research team to develop highly effective and precise skincare solutions from the perspective of skin’s native structures. In this study, the team focused on Osteopeptide as the core active ingredient and, through extensive experiments and data analysis, systematically verified for the first time its innovative mechanism in stabilizing collagen architecture within the skin. Results demonstrated that Osteopeptide not only significantly enhances skin elasticity and firmness but also provides multifunctional benefits including hydration, anti-inflammatory, and antioxidant effects. This breakthrough offers new scientific evidence supporting zone-specific anti-aging.

Looking ahead, Blé de Fonty will continue to deepen its research in skincare science. Building on this milestone, the brand aims to further optimize its existing product lines while accelerating the exploration of new active ingredients and technologies. With a commitment to science-based innovation, Blé de Fonty pledges to deliver superior and more personalized skincare experiences to consumers worldwide, spearheading a new era of precision skincare.